Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | LGALS1 | P09382 | 2/20 | 0.47 |
| ▸ | LGALS3 | P17931 | 2/20 | 0.47 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.47 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.47 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | CA12 | O43570 | 3/20 | 0.38 |
| ▸ | CA1 | P00915 | 3/20 | 0.38 |
| ▸ | CA2 | P00918 | 3/20 | 0.38 |
| ▸ | CA9 | Q16790 | 3/20 | 0.38 |
| ▸ | OGA | O60502 | 1/20 | 0.37 |
| ▸ | HEXB | P07686 | 1/20 | 0.37 |
| ▸ | PYGB | P11216 | 4/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6297129 | 1.00 | L3MBTL1 (0.47) | L3MBTL1LGALS1LGALS3LGALS9LGALS8 | |
| SCHEMBL15820316 | 1.00 | L3MBTL1 (0.47) | L3MBTL1LGALS1LGALS3LGALS9LGALS8 | |
| SCHEMBL1445509 | 1.00 | L3MBTL1 (0.47) | L3MBTL1LGALS1LGALS3LGALS9LGALS8 | |
| SCHEMBL12599990 | 1.00 | L3MBTL1 (0.47) | L3MBTL1LGALS1LGALS3LGALS9LGALS8 | |
| SCHEMBL1445770 | 1.00 | L3MBTL1 (0.47) | L3MBTL1LGALS1LGALS3LGALS9LGALS8 | |
| SCHEMBL1445720 | 1.00 | L3MBTL1 (0.47) | L3MBTL1LGALS1LGALS3LGALS9LGALS8 | |
| SCHEMBL4796941 | 1.00 | L3MBTL1 (0.47) | L3MBTL1LGALS1LGALS3LGALS9LGALS8 | |
| SCHEMBL29249548 | 0.98 | L3MBTL1 (0.44) | L3MBTL1LGALS1LGALS3LGALS9LGALS8 | |
| SCHEMBL17087884 | 0.98 | L3MBTL1 (0.44) | L3MBTL1LGALS1LGALS3LGALS9LGALS8 | |
| SCHEMBL16056055 | 0.98 | L3MBTL1 (0.44) | L3MBTL1LGALS1LGALS3LGALS9LGALS8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3052134-B1 | GLUCOSE-RESPONSIVE INSULIN CONJUGATES | MERCK SHARP & DOHME (US) | 2021-05-05 | — | — | EP | disclosed |
| CN-105792852-B | Glucose-responsive insulin conjugates | 默沙东公司 | 2019-12-10 | — | — | CN | disclosed |
| US-20180110863-A1 | GLUCOSE-RESPONSIVE INSULIN CONJUGATES | MERCK SHARP & DOHME CORP. (US) | 2018-04-26 | — | — | US | disclosed |
| EP-3280450-A1 | GLUCOSE-RESPONSIVE INSULIN CONJUGATES | Merck Sharp & Dohme Corp. (US) | 2018-02-14 | — | — | EP | disclosed |
| US-9889205-B2 | Glucose-responsive insulin conjugates | MERCK SHARP & DOHME CORP. (US) | 2018-02-13 | — | — | US | disclosed |
| US-9884125-B2 | Glucose-responsive insulin conjugates | MERCK SHARP & DOHME CORP. (US) | 2018-02-06 | — | — | US | disclosed |
| US-20160303244-A1 | GLUCOSE-RESPONSIVE INSULIN CONJUGATES | MERCK SHARP & DOHME CORP. (US) | 2016-10-20 | — | — | US | disclosed |
| WO-2016164288-A1 | GLUCOSE-RESPONSIVE INSULIN CONJUGATES | MERCK SHARP & DOHME CORP. (US) | 2016-10-13 | — | — | WO | disclosed |
| US-20160251407-A1 | GLUCOSE-RESPONSIVE INSULIN CONJUGATES | MERCK SHARP & DOHME CORP. (US) | 2016-09-01 | — | — | US | disclosed |
| US-9427475-B2 | Glucose-responsive insulin conjugates | MERCK SHARP & DOHME CORP. (US) | 2016-08-30 | — | — | US | disclosed |
| EP-3052134-A2 | GLUCOSE-RESPONSIVE INSULIN CONJUGATES | Merck Sharp & Dohme Corp. (US) | 2016-08-10 | — | — | EP | disclosed |
| US-20150105317-A1 | GLUCOSE-RESPONSIVE INSULIN CONJUGATES | MERCK SHARP & DOHME LLC | 2015-04-16 | — | — | US | disclosed |
| WO-2015051052-A2 | GLUCOSE-RESPONSIVE INSULIN CONJUGATES | MERCK SHARP & DOHME CORP. (US) | 2015-04-09 | — | — | WO | disclosed |
| US-20120178913-A1 | OLEFIN METATHESIS REACTIONS OF AMINO ACIDS, PEPTIDES AND PROTEINS CONTAINING ALLYL SULFIDE GROUPS | ISIS INNOVATION LIMITED (GB) | 2012-07-12 | — | — | US | disclosed |
| EP-2288614-A1 | OLEFIN METATHESIS REACTIONS OF AMINO ACIDS, PEPTIDES AND PROTEINS CONTAINING ALLYL SULFIDE GROUPS | ISIS Innovation Limited (GB) | 2011-03-02 | — | — | EP | disclosed |
| WO-2009147414-A1 | OLEFIN METATHESIS REACTIONS OF AMINO ACIDS, PEPTIDES AND PROTEINS CONTAINING ALLYL SULFIDE GROUPS | ISIS INNOVATION LIMITED (GB) | 2009-12-10 | — | — | WO | disclosed |
| EP-1446391-A4 | PREPARATION AND USE OF CARBOHYDRATE-BASED RING STRUCTURES WITH ANTIMICROBIAL AND CYTOSTATIC ACTIVITY | KEMIN PHARMA EUROP (US) | 2008-02-20 | — | — | EP | disclosed |
| WO-2005000873-A1 | PREPARATION OF GLYCOSYLATED AMINO ACIDS, PROTEINS AND PEPTIDES VIA OLEFIN METATHESIS REACTIONS | ISIS INNOVATION LIMITED (GB) | 2005-01-06 | — | — | WO | disclosed |
| EP-1446391-A2 | PREPARATION AND USE OF CARBOHYDRATE-BASED RING STRUCTURES WITH ANTIMICROBIAL AND CYTOSTATIC ACTIVITY | Kemin Pharma Europe (US) | 2004-08-18 | — | — | EP | disclosed |
| WO-2003032905-A2 | PREPARATION AND USE OF CARBOHYDRATE-BASED RING STRUCTURES WITH ANTIMICROBIAL AND CYTOSTATIC ACTIVITY | KEMIN PHARMA EUROPE (US) | 2003-04-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180110863-A1 | GLUCOSE-RESPONSIVE INSULIN CONJUGATES | GPR119, INSR, IRS1 | L3MBTL1 1778/4885LGALS1 824/4885LGALS3 1372/4885 |
| US-20150105317-A1 | GLUCOSE-RESPONSIVE INSULIN CONJUGATES | GPR119, INSR, IRS1 | L3MBTL1 1526/4885LGALS1 582/4885LGALS3 1046/4885 |
| US-20160251407-A1 | GLUCOSE-RESPONSIVE INSULIN CONJUGATES | GPR119, INSR, IRS1 | L3MBTL1 1356/4885LGALS1 565/4885LGALS3 967/4885 |
| US-20120178913-A1 | OLEFIN METATHESIS REACTIONS OF AMINO ACIDS, PEPTIDES AND PROTEINS CONTAINING ALLYL SULFIDE GROUPS | MAX, PTMS, OSBP | L3MBTL1 1453/4885LGALS1 2780/4885LGALS3 3462/4885 |
| US-20160303244-A1 | GLUCOSE-RESPONSIVE INSULIN CONJUGATES | GPR119, INSR, IRS1 | L3MBTL1 1526/4885LGALS1 582/4885LGALS3 1046/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.